ABCB1 and ovarian carcinoma: A 2019 report on ovarian cancer introduced Erastin, a ferroptosis inducer, which countered docetaxel resistance mediated by ABCB1 (a pathway promoting drug efflux from cells) [115] and promoted ferroptosis in ovarian cancer cells.